[{"NetIncomeLoss_2_Q2_USD":-50906000.0,"Liabilities_0_Q2_USD":56258000.0,"OperatingLeaseLiability_0_Q2_USD":16270000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q2_USD":7300000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":61755000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":15473000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":14894000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":20756000.0,"InterestPaidNet_2_Q2_USD":9000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":749000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-574134000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":7484000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":710000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":3991000.0,"AssetsCurrent_0_Q2_USD":371346000.0,"OperatingLeaseExpense_2_Q2_USD":1477000.0,"OperatingLeaseExpense_1_Q2_USD":902000.0,"SellingAndMarketingExpense_2_Q2_USD":35958000.0,"SellingAndMarketingExpense_1_Q2_USD":19662000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":4803895.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":4760414.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":3880000.0,"CommonStockSharesIssued_0_Q2_shares":67471551.0,"Assets_0_Q2_USD":1027435000.0,"ShareBasedCompensation_2_Q2_USD":7919000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":14559000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":11104580.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1303610000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":13334000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":327545000.0,"OtherAssetsNoncurrent_0_Q2_USD":1504000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":11585000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":6249000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":19246000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":16020000.0,"EarningsPerShareBasic_2_Q2_USD":-0.78,"EarningsPerShareBasic_1_Q2_USD":-0.13,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":14894000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-1797000.0,"InventoryWriteDown_2_Q2_USD":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":65334890.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":67316065.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-1848000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-1653000.0,"AccountsReceivableNetCurrent_0_Q2_USD":31864000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"IncomeTaxExpenseBenefit_2_Q2_USD":-3947000.0,"CommonStockValue_0_Q2_USD":67000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":7050000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":171720000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":-1866000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":592932000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":247000.0,"CostsAndExpenses_2_Q2_USD":144697000.0,"CostsAndExpenses_1_Q2_USD":62579000.0,"IncreaseDecreaseInInventories_2_Q2_USD":375000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-50906000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-9038000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":2758000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":5524000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":3723000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-152000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":30000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":2976000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":574411000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-38674000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":65334890.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":67316065.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":3375000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":3770000.0,"LiabilitiesCurrent_0_Q2_USD":36105000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":-19876000.0,"AccountsPayableCurrent_0_Q2_USD":8472000.0,"InterestExpense_2_Q2_USD":116000.0,"InterestExpense_1_Q2_USD":63000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":328294000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":5263000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":6595000.0,"LongTermDebtNoncurrent_0_Q2_USD":917000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":8156000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":155700000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.067,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_2_Q2_USD":38677000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":1159000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":148400000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"OperatingLeasePayments_2_Q2_USD":1507000.0,"OperatingLeasePayments_1_Q2_USD":919000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":773000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":1019000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":4467000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":11813000.0,"NetIncomeLoss_1_Q2_USD":-9038000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":7484000.0,"Goodwill_0_Q2_USD":471764000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":14854000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":14408000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1288000.0,"CommonStockSharesAuthorized_0_Q2_shares":125000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":91808000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":55105000.0,"OperatingIncomeLoss_2_Q2_USD":-52889000.0,"OperatingIncomeLoss_1_Q2_USD":-7474000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-54853000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-9190000.0,"ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_2_Q2_USD":3000000.0,"InventoryNet_0_Q2_USD":6674000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":593821000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":566000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":164420000.0,"PreferredStockValue_0_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":4103000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-3947000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":12600000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2936000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":7448000.0,"GoodwillAcquiredDuringPeriod_2_Q2_USD":469039000.0,"StockholdersEquity_0_Q2_USD":971177000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":662000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":2723000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-332500000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-21673000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":6713000.0,"CommonStockSharesOutstanding_0_Q2_shares":67471551.0,"EarningsPerShareDiluted_2_Q2_USD":-0.78,"EarningsPerShareDiluted_1_Q2_USD":-0.13,"LiabilitiesAndStockholdersEquity_0_Q2_USD":1027435000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1841000.0,"Ticker":"VCYT","CIK":"1384101","name":"VERACYTE, INC.","OfficialName":"Veracyte Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"1700692789.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210729"}]